{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T22:55:00Z","timestamp":1783551300959,"version":"3.55.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,9]],"date-time":"2024-12-09T00:00:00Z","timestamp":1733702400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003977","name":"Israel Science Foundation","doi-asserted-by":"publisher","award":["1456\/19"],"award-info":[{"award-number":["1456\/19"]}],"id":[{"id":"10.13039\/501100003977","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001742","name":"United States-Israel Binational Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001742","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006221","name":"United States - Israel Binational Science Foundation","doi-asserted-by":"publisher","award":["2019098"],"award-info":[{"award-number":["2019098"]}],"id":[{"id":"10.13039\/100006221","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Tumour Virus Research"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.tvr.2024.200303","type":"journal-article","created":{"date-parts":[[2024,12,15]],"date-time":"2024-12-15T04:20:59Z","timestamp":1734236459000},"page":"200303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["The adenoviral E4orf4 protein: A multifunctional protein serving as a guide for treating cancer, a multifactorial disease"],"prefix":"10.1016","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-9746-0938","authenticated-orcid":false,"given":"Amir","family":"Basis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakefet","family":"Sharf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0300-8679","authenticated-orcid":false,"given":"Tamar","family":"Kleinberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tvr.2024.200303_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejca.2004.04.036","article-title":"The treatment of cancer in Greek antiquity","volume":"40","author":"Karpozilos","year":"2004","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.tvr.2024.200303_bib2","article-title":"Cancer statistics","volume":"74","author":"Siegel","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.tvr.2024.200303_bib3","series-title":"Cancer Nursing: Care in Context","author":"Corner","year":"2008"},{"key":"10.1016\/j.tvr.2024.200303_bib4","author":"Mould"},{"key":"10.1016\/j.tvr.2024.200303_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S0090-8258(03)00110-0","article-title":"(1909-2002): the cure of choriocarcinoma and its impact on the development of chemotherapy for cancer","volume":"89","author":"Yarris","year":"2003","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.tvr.2024.200303_bib6","author":"Zahavi"},{"key":"10.1016\/j.tvr.2024.200303_bib7","article-title":"Oncolytic virotherapy: basic principles, recent advances and future directions","volume":"8","author":"Lin","year":"2023","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/j.tvr.2024.200303_bib8","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.breast.2013.09.009","article-title":"Biological therapies in breast cancer: common toxicities and management strategies","volume":"22","author":"Barroso-Sousa","year":"2013","journal-title":"Breast"},{"key":"10.1016\/j.tvr.2024.200303_bib9","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1080\/14737140.2018.1527688","article-title":"A comprehensive review of protein kinase inhibitors for cancer therapy","volume":"18","author":"Kannaiyan","year":"2018","journal-title":"Expert Rev. Anticancer Ther."},{"key":"10.1016\/j.tvr.2024.200303_bib10","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the Next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.tvr.2024.200303_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","article-title":"The hallmarks of cancer","volume":"100","author":"Hanahan","year":"2000","journal-title":"Cell"},{"key":"10.1016\/j.tvr.2024.200303_bib12","article-title":"Mechanisms of drug combinations: interaction and network perspectives","volume":"8","author":"Jia","year":"2009","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tvr.2024.200303_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/nbt.2284","article-title":"Combinatorial drug therapy for cancer in the post-genomic era","volume":"30","author":"Al-Lazikani","year":"2012","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.tvr.2024.200303_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006667","article-title":"High-throughput methods for combinatorial drug discovery","volume":"5","author":"Sun","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.tvr.2024.200303_bib15","first-page":"456","article-title":"A new look at adenovirus splicing","author":"Zhao","year":"2014","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200303_bib16","doi-asserted-by":"crossref","DOI":"10.1074\/jbc.M112.343756","article-title":"Structure- and modeling-based identification of the adenovirus E4orf4 binding site in the protein phosphatase 2A B55\u03b1 subunit","volume":"288","author":"Horowitz","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.tvr.2024.200303_bib17","doi-asserted-by":"crossref","DOI":"10.1007\/s12033-024-01278-4","article-title":"Identification of the potential role of the E4orf4 protein in adenovirus A, B, C, and D groups in cancer therapy: computational approaches","author":"Khakpour","year":"2024","journal-title":"Mol. Biotechnol."},{"key":"10.1016\/j.tvr.2024.200303_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/1873-3468.13704","article-title":"Biology of the adenovirus E4orf4 protein: from virus infection to cancer cell death","volume":"594","author":"Kleinberger","year":"2020","journal-title":"FEBS Lett."},{"key":"10.1016\/j.tvr.2024.200303_bib19","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.03710-14","article-title":"The human adenovirus type 5 E4orf4 protein targets two phosphatase regulators of the hippo signaling pathway","volume":"89","author":"Mui","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200303_bib20","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.02253-18","article-title":"An interaction with PARP-1 and inhibition of parylation contribute to attenuation of DNA damage signaling by the adenovirus E4orf4 protein","volume":"93","author":"Nebenzahl-Sharon","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200303_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005420","article-title":"The adenovirus E4orf4 protein provides a novel mechanism for inhibition of the DNA damage response","volume":"12","author":"Brestovitsky","year":"2016","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tvr.2024.200303_bib22","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01365-18","article-title":"Biphasic functional interaction between the adenovirus E4orf4 protein and DNA-PK","volume":"93","author":"Nebenzahl-Sharon","year":"2019","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200303_bib23","doi-asserted-by":"crossref","DOI":"10.2741\/ben","article-title":"Adenovirus and cell cycle control","volume":"7","author":"Ben-Israel","year":"2002","journal-title":"Front. Biosci."},{"key":"10.1016\/j.tvr.2024.200303_bib24","article-title":"Adenovirus E4orf4 protein induces PP2A-dependent growth arrest in Saccharomyces cerevisiae and interacts with the anaphase-promoting complex\/cyclosome","volume":"154","author":"Kornitzer","year":"2001","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.tvr.2024.200303_bib25","doi-asserted-by":"crossref","DOI":"10.1038\/sj.onc.1204693","article-title":"Toxicity of human adenovirus E4orf4 protein in Saccharomyces cerevisiae results from interactions with the Cdc55 regulatory B subunit of PP2A","volume":"20","author":"Roopchand","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.tvr.2024.200303_bib26","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.03437-14","article-title":"Analysis by live imaging of effects of the adenovirus E4orf4 protein on passage through mitosis of H1299 tumor cells","volume":"89","author":"Sriskandarajah","year":"2015","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200303_bib27","doi-asserted-by":"crossref","DOI":"10.1038\/onc.2008.393","article-title":"The adenovirus E4orf4 protein induces growth arrest and mitotic catastrophe in H1299 human lung carcinoma cells","volume":"28","author":"Li","year":"2009","journal-title":"Oncogene"},{"key":"10.1016\/j.tvr.2024.200303_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.virol.2007.05.043","article-title":"G2\/M cell cycle arrest in the life cycle of viruses","volume":"368","author":"Davy","year":"2007","journal-title":"Virology"},{"key":"10.1016\/j.tvr.2024.200303_bib29","article-title":"PI3K signaling-regulated metabolic reprogramming: from mechanism to application","volume":"1878","author":"Su","year":"2023","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.tvr.2024.200303_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/nature12912","article-title":"Discovery and saturation analysis of cancer genes across 21 tumour types","volume":"505","author":"Lawrence","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.tvr.2024.200303_bib31","doi-asserted-by":"crossref","DOI":"10.1038\/nrc.2016.77","article-title":"Reprogramming glucose metabolism in cancer: can it be exploited for cancer therapy?","volume":"16","author":"Hay","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.tvr.2024.200303_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1004102","article-title":"The human adenovirus E4-ORF1 protein subverts discs large 1 to mediate membrane recruitment and dysregulation of phosphatidylinositol 3-kinase","volume":"10","author":"Kong","year":"2014","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.tvr.2024.200303_bib33","doi-asserted-by":"crossref","DOI":"10.1038\/sj.emboj.7600597","article-title":"Adenoviral proteins mimic nutrient\/growth signals to activate the mTOR pathway for viral replication","volume":"24","author":"O'Shea","year":"2005","journal-title":"EMBO J."},{"key":"10.1016\/j.tvr.2024.200303_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2014.03.009","article-title":"Adenovirus E4ORF1-induced MYC activation promotes host cell anabolic glucose metabolism and virus replication","volume":"19","author":"Thai","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/j.tvr.2024.200303_bib35","article-title":"E4orf4, a novel adenovirus death factor that induces p53-independent apoptosis by a pathway that is not inhibited by zVAD-fmk","volume":"140","author":"Lavoie","year":"1998","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.tvr.2024.200303_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.72.9.7144-7153.1998","article-title":"The early region 4 orf4 protein of human adenovirus type 5 induces p53-independent cell death by apoptosis","volume":"72","author":"Marcellus","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200303_bib37","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.72.4.2975-2982.1998","article-title":"Adenovirus type 5 E4 open reading frame 4 protein induces apoptosis in transformed cells","volume":"72","author":"Shtrichman","year":"1998","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200303_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/sj.onc.1204862","article-title":"The role of adenovirus E4orf4 protein in viral replication and cell killing","volume":"20","author":"Branton","year":"2001","journal-title":"Oncogene"},{"key":"10.1016\/j.tvr.2024.200303_bib39","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.96.18.10080","article-title":"Induction of apoptosis by adenovirus E4orf4 protein is specific to transformed cells and requires an interaction with protein phosphatase 2A","volume":"96","author":"Shtrichman","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tvr.2024.200303_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-019-1680-4","article-title":"Selective elimination of cancer cells by the adenovirus E4orf4 protein in a Drosophila cancer model: a new paradigm for cancer therapy","volume":"10","author":"Rosen","year":"2019","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.tvr.2024.200303_bib41","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.1220282110","article-title":"E4orf4 induces PP2A- and Src-dependent cell death in Drosophila melanogaster and at the same time inhibits classic apoptosis pathways","volume":"110","author":"Pechkovsky","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.tvr.2024.200303_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00381-14","article-title":"NTPDASE4 gene products cooperate with the adenovirus E4orf4 protein through PP2A-dependent and -independent mechanisms and contribute to induction of cell death","volume":"88","author":"Avital-Shacham","year":"2014","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200303_bib43","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkr231","article-title":"The adenovirus E4orf4 protein targets PP2A to the ACF chromatin-remodeling factor and induces cell death through regulation of SNF2h-containing complexes","volume":"39","author":"Brestovitsky","year":"2011","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.tvr.2024.200303_bib44","article-title":"Adenoviral protein E4orf4 interacts with the polarity protein par3 to induce nuclear rupture and tumor cell death","volume":"219","author":"Dziengelewski","year":"2020","journal-title":"JCB (J. Cell Biol.)"},{"key":"10.1016\/j.tvr.2024.200303_bib45","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.75.2.789-798.2001","article-title":"Caspase activation by adenovirus E4orf4 protein is cell line specific and is mediated by the death receptor pathway","volume":"75","author":"Livne","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.tvr.2024.200303_bib46","doi-asserted-by":"crossref","DOI":"10.1091\/mbc.e05-12-1146","article-title":"Adenovirus E4orf4 hijacks Rho GTPase-dependent actin dynamics to kill cells: a role for endosome-associated actin assembly","volume":"17","author":"Robert","year":"2006","journal-title":"Mol. Biol. Cell"},{"key":"10.1016\/j.tvr.2024.200303_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/bcp.12761","article-title":"Olaparib","volume":"81","author":"Goulooze","year":"2016","journal-title":"Br. J. Clin. Pharmacol."},{"key":"10.1016\/j.tvr.2024.200303_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/1097-0142(20000601)88:11<2619::AID-CNCR26>3.0.CO;2-J","article-title":"Paclitaxel-induced cell death: where the cell cycle and apoptosis come together","volume":"88","author":"Wang","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.tvr.2024.200303_bib49","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMe1400055","article-title":"Idelalisib \u2014 a PI3K\u03b4 inhibitor for B-cell cancers","volume":"370","author":"Fruman","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tvr.2024.200303_bib50","article-title":"Bleomycin pharmacology: mechanism of action and resistance, and clinical pharmacokinetics","volume":"19","author":"Dorr","year":"1992","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.tvr.2024.200303_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/nprot.2006.179","article-title":"Sulforhodamine B colorimetric assay for cytotoxicity screening","volume":"1","author":"Vichai","year":"2006","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.tvr.2024.200303_bib52","doi-asserted-by":"crossref","DOI":"10.1046\/j.1432-1327.2000.01606.x","article-title":"Investigation of the Alamar Blue (resazurin) fluorescent dye for the assessment of mammalian cell cytotoxicity","volume":"267","author":"O'Brien","year":"2000","journal-title":"Eur. J. Biochem."},{"key":"10.1016\/j.tvr.2024.200303_bib53","article-title":"Evaluation of synergism in drug combinations and reference models for future orientations in oncology, Current Research","volume":"3","author":"Duarte","year":"2022","journal-title":"Pharmacology and Drug Discovery"},{"key":"10.1016\/j.tvr.2024.200303_bib54","doi-asserted-by":"crossref","first-page":"a007161","DOI":"10.1101\/cshperspect.a007161","article-title":"HIV-1 antiretroviral drug therapy","volume":"2","author":"Arts","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.tvr.2024.200303_bib55","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201439949","article-title":"Oncogene addiction: pathways of therapeutic response, resistance, and road maps toward a cure","volume":"16","author":"Pagliarini","year":"2015","journal-title":"EMBO Rep."},{"key":"10.1016\/j.tvr.2024.200303_bib56","article-title":"Implications of viral infection in cancer development","volume":"1876","author":"Kellogg","year":"2021","journal-title":"Biochim. Biophys. Acta Rev. Canc"},{"key":"10.1016\/j.tvr.2024.200303_bib57","doi-asserted-by":"crossref","first-page":"961","DOI":"10.4161\/cbt.10.10.13923","article-title":"Tumor viruses and cancer biology: modulating signaling pathways for therapeutic intervention","volume":"10","author":"Saha","year":"2010","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.tvr.2024.200303_bib58","doi-asserted-by":"crossref","DOI":"10.1128\/mbio.00462-24","article-title":"What are the essential determinants of human papillomavirus carcinogenesis?","volume":"15","author":"Munger","year":"2024","journal-title":"mBio"},{"key":"10.1016\/j.tvr.2024.200303_bib59","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.virol.2008.09.034","article-title":"The common mechanisms of transformation by the small DNA tumor viruses: the inactivation of tumor suppressor gene products: p53","volume":"384","author":"Levine","year":"2009","journal-title":"Virology"}],"container-title":["Tumour Virus Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679024000272?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666679024000272?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,13]],"date-time":"2025-06-13T07:48:00Z","timestamp":1749800880000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666679024000272"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":59,"alternative-id":["S2666679024000272"],"URL":"https:\/\/doi.org\/10.1016\/j.tvr.2024.200303","relation":{},"ISSN":["2666-6790"],"issn-type":[{"value":"2666-6790","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The adenoviral E4orf4 protein: A multifunctional protein serving as a guide for treating cancer, a multifactorial disease","name":"articletitle","label":"Article Title"},{"value":"Tumour Virus Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tvr.2024.200303","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200303"}}